Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine[J]. J Am Dent Assoc, 1987,114(1): 56-60.
[2]
Garzini-Demo P, Carbone M, Carrozzo M, et al. An increase in gingival volume induced by drugs (phenytoin, cyclosporine and calcium antagonists). A review of the literature[J]. Minerva Stomatologica, 1998,47(9): 387-398.
[3]
Spratt H, Boomer S, Irwin CR, et al. Cyclosporine associated gingival overgrowth in renal transplant recipients[J]. Oral Diseases, 1999,5(1): 27-31.
[4]
Vescovi P, Savi A, Macaluso GM, et al. Gingival hypertrophy due to cyclosporine. A clinico-statistical study in 82 patients[J]. Minerva Stomatologica, 1997, 46(4): 155-164.
[5]
O’Leary TJ, Drake RB, Naylord JE. The plaque control record[J]. J Periodontol, 1972, 43(1): 38.
[6]
Silness J, L？e H. Periodontal disease in pregnancy. Ⅱ. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand, 1964, 22: 121-135.
[7]
Rateitschak-Plüss EM, Hefti A, L？rtscher R, et al. Initial observation that cyclosporine-A induces gingival enlargement in man[J]. J Clin Periodontol, 1983, 10(3): 237-246.
[8]
Wong W, Hodge MG, Lewis A, et al. Resolution of cyclosporine induced gingival hypertrophy with metronidazole[J]. Lancet, 1994, 343(8903): 986.
Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth[J]. Crit Rev Oral Biol Med, 2004, 15(3): 165-175.
[11]
Bulut S, Ozdemir BH, Alaaddinoglu EE, et al. Effect of cyclosporin A on apoptosis and expression of p53 and bcl-2 proteins in the gingiva of renal transplant patients[J]. J Periodontol, 2005, 76(5): 691-695.
Mustapha IZ, Debrey S, Oladubu M, et al. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis[J]. J Periodontol, 2007, 78(12): 2289-2302.
James JA, Boomer S, Maxwell AP,et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus[J]. J Clin Periodontol, 2000, 27(2): 144-148.
[16]
Margreiter R, European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal ransplantation: a randomised multicentre study[J]. Lancet, 2002, 359(9308): 741-746.
[17]
Somacarrera ML, Lucas M, Scully C, et al. Effectiveness of periodontal treatments on cyclosporin-induced gingival overgrowth in transplant patients[J]. Br Dent J, 1997, 183(3): 89-94.
[18]
Kantarci A, Cebeci I, Tuncer O, et al. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingivalhyperplasia[J]. J Periodontol, 1999, 70(6): 587-593.
First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation[J]. J Am Soc Nephrol, 1994, 4(Suppl 8): s30-s36.
[21]
Schwenger V, Zeier M, Ritz E, et al. Hypertension after renal transplantation[J]. Curr Hypertens Rep, 2001, 3(5): 434-439.
[22]
Zeier M, Mandelbaum A, Ritz E, et al. Hypertension in th
[23]
e transplanted patient[J]. Nephron, 1998, 80(3), 257-268.
[24]
Tutone VK, Mark PB, Stewart GA,et al. Hypertension, antihypertensive agents and outcomes following renal transplantation[J]. Clin Transplant, 2005, 19(2): 181-192.
[25]
Morton RS, Dongari-Bagtzoglou AI. Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A[J]. J Periodontol, 1999, 70(12): 1464-1471.
